41 related articles for article (PubMed ID: 19443388)
21. Correlation between WT1 expression and cell proliferation in endometrial cancer.
Dohi S; Ohno S; Ohno Y; Soma G; Kyo S; Inoue M
Anticancer Res; 2009 Nov; 29(11):4887-91. PubMed ID: 20032452
[TBL] [Abstract][Full Text] [Related]
22. WT1 expression correlates with angiogenesis in endometrial cancer tissue.
Dohi S; Ohno S; Ohno Y; Kyo S; Soma G; Sugiyama H; Inoue M
Anticancer Res; 2010 Aug; 30(8):3187-92. PubMed ID: 20871039
[TBL] [Abstract][Full Text] [Related]
23. Wilms Tumor Gene (WT1) and p53 expression in endometrial carcinomas: a study of 130 cases using a tissue microarray.
Dupont J; Wang X; Marshall DS; Leitao M; Hedvat CV; Hummer A; Thaler H; O'Reilly RJ; Soslow RA
Gynecol Oncol; 2004 Aug; 94(2):449-55. PubMed ID: 15297187
[TBL] [Abstract][Full Text] [Related]
24. Expression of NLRP7 (PYPAF3, NALP7) protein in endometrial cancer tissues.
Ohno S; Kinoshita T; Ohno Y; Minamoto T; Suzuki N; Inoue M; Suda T
Anticancer Res; 2008; 28(4C):2493-7. PubMed ID: 18751440
[TBL] [Abstract][Full Text] [Related]
25. Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer: from the Danish "MALOVA" ovarian cancer study.
Høgdall EV; Christensen L; Kjaer SK; Blaakaer J; Christensen IJ; Gayther S; Jacobs IJ; Høgdall CK
Gynecol Oncol; 2007 Aug; 106(2):318-24. PubMed ID: 17540436
[TBL] [Abstract][Full Text] [Related]
26. [Immunotherapy targeting the Wilms' tumor 1 gene product for patients with malignant brain tumors].
Hashimoto N; Tsuboi A; Chiba Y; Izumoto S; Oka Y; Yoshimine T; Sugiyama H
Brain Nerve; 2009 Jul; 61(7):805-14. PubMed ID: 19618858
[TBL] [Abstract][Full Text] [Related]
27. The role of WT1 in breast cancer: clinical implications, biological effects and molecular mechanism.
Zhang Y; Yan WT; Yang ZY; Li YL; Tan XN; Jiang J; Zhang Y; Qi XW
Int J Biol Sci; 2020; 16(8):1474-1480. PubMed ID: 32210734
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic and Prognostic Role of WT1 Immunohistochemical Expression in Uterine Carcinoma: A Systematic Review and Meta-Analysis across All Endometrial Carcinoma Histotypes.
Angelico G; Santoro A; Straccia P; Inzani F; Cianfrini F; Spadola S; Arciuolo D; Valente M; D'Alessandris N; Mulè A; Zannoni GF
Diagnostics (Basel); 2020 Aug; 10(9):. PubMed ID: 32859123
[No Abstract] [Full Text] [Related]
29. Immunohistochemical detection of WT1 protein in endometrial cancer.
Ohno S; Dohi S; Ohno Y; Kyo S; Sugiyama H; Suzuki N; Inoue M
Anticancer Res; 2009 May; 29(5):1691-5. PubMed ID: 19443388
[TBL] [Abstract][Full Text] [Related]
30. Cancer immunotherapy targeting Wilms' tumor gene WT1 product.
Sugiyama H
Expert Rev Vaccines; 2005 Aug; 4(4):503-12. PubMed ID: 16117707
[TBL] [Abstract][Full Text] [Related]
31. Immunotherapeutic targeting of Wilms' tumor protein.
Hutchings Y; Osada T; Woo CY; Clay TM; Lyerly HK; Morse MA
Curr Opin Mol Ther; 2007 Feb; 9(1):62-9. PubMed ID: 17330403
[TBL] [Abstract][Full Text] [Related]
32. The role of the Wilms' tumour-suppressor protein WT1 in apoptosis.
Hartkamp J; Roberts SG
Biochem Soc Trans; 2008 Aug; 36(Pt 4):629-31. PubMed ID: 18631130
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]